Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve This is to intimate ....
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed exchanges that its Board of Directors will meet on Thursday, 13 November 2025. The key agenda is to consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and half year ended 30 September 2025 (Q2 FY26). Any other business may be taken up with the Chairman's consent. The trading window for insiders is already closed from 1 October 2025 and will remain closed until 48 hours after the results are announced. The intimation is signed by Director Mihir Ghatalia (DIN: 00581005).
Routine regulatory intimation with no material business action. Investors should watch the Q2/H1 FY26 results announcement on or shortly after 13 November for actual financial performance, which could move the stock depending on the numbers.